Hallucinogens
Research News and Information

Monday, November 23, 2009

The psychotomimetic effects of short-term sensory deprivation.

29 Sep 2009 People experiencing sensory deprivation often report perceptual disturbances such as hallucinations, especially over extended periods of time. However, there is little evidence concerning short-term sensory deprivation and whether its effects differ ... Read more...

Methylenedioxymethamphetamine-related deaths in Taiwan: 2001-2008.

30 Aug 2009 Methylenedioxymethamphetamine (MDMA) has been one of most popular drugs in the "club" scene in Taiwan. This epidemic was studied through the examination of toxicological data obtained from the 59 fatalities tested positive for MDMA during the period ... Read more...

Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil.

30 Jul 2009 Although it is commonly stated that phencyclidine is an antagonist at ionotropic glutamate receptors, there has been little measure of its potency on other receptors in brain tissue. Although we previously reported that phencyclidine stimulated ... Read more...

Latest indexed articles for 'Hallucinogens'

These are the very latest articles for this heading:

• The psychotomimetic effects of short-term sensory deprivation. 29 Sep 2009
• Return of a problem child. 29 Sep 2009
• Methylenedioxymethamphetamine-related deaths in Taiwan: 2001-2008. 30 Aug 2009
• Neuroscience. Salvia on schedule. 30 Jul 2009
• Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil. 30 Jul 2009
• A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists. Jul 2009
• Modulation of MDMA-induced behavioral and transcriptional effects by the delta opioid antagonist naltrindole in mice. 29 Jun 2009
• Bioanalytical and clinical evaluation of 103 suspected cases of intoxications with psychoactive plant materials. 29 Jun 2009
• Characterisation of a proposed internet synthesis of N,N-dimethyltryptamine using liquid chromatography/electrospray ionisation tandem mass spectrometry. 21 Jun 2009
• Differential changes in mesolimbic dopamine following contingent and non-contingent MDMA self-administration in mice. 2 Jun 2009
• Hallucinogen-related disorders in a national sample of adolescents: the influence of ecstasy/MDMA use. 2 Jun 2009
• PSD-95 is essential for hallucinogen and atypical antipsychotic drug actions at serotonin receptors. Jun 2009
• I promise I won't. 30 May 2009
• A comparison between experimental and authentic blood/serum ratios of 3,4-methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine. 30 May 2009
• Changes in spirituality among ayahuasca ceremony novice participants. 30 May 2009
• [Unilatelaral iris plateau syndrome after the use of ecstasy] 30 May 2009
• Molecular dynamics simulation of the heterodimeric mGluR2/5HT(2A) complex. An atomistic resolution study of a potential new target in psychiatric conditions. 30 May 2009
• Evaluation of the transport, in vitro metabolism and pharmacokinetics of Salvinorin A, a potent hallucinogen. 30 May 2009
• Anesthetic implications of acute methylenedioxymethamphetamine intoxication in a patient with traumatic intracerebral hemorrhage. 30 May 2009
• What signs and symptoms would be expected after ingestion of this plant? 30 May 2009

See a longer list of these articles.

Technical information about 'Hallucinogens'

Definition: Drugs capable of inducing illusions, hallucinations, delusions, paranoid ideations, and other alterations of mood and thinking. Despite the name, the feature that distinguishes these agents from other classes of drugs is their capacity to induce states of altered perception, thought, and feeling that are not experienced otherwise.

Registry Number: 0

Descriptor UI: D006213

Alternative terms: Hallucinogens; Psychotomimetic Agents; Agents, Psychotomimetic; Hallucinogenic Agents; Agents, Hallucinogenic; Hallucinogenic Substances; Substances, Hallucinogenic; Psychedelics; Psychedelic Agents; Agents, Psychedelic; Hallucinogenic Drugs; Drugs, Hallucinogenic;

Related Mesh Headings: Hallucinations;

Allowable Qualifiers: chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists; administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid;

Tree Number: D27.505.696.388; D27.505.954.427.300; D27.505.954.427.700.372;

Technical Notes: GEN or unspecified; prefer specifics; consider also HALLUCINATIONS /chem ind